{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:39:27Z","timestamp":1791128367962,"version":"4.1.0"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/cmr.0b013e32835fb524","type":"journal-article","created":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T14:39:06Z","timestamp":1362235146000},"page":"227-230","source":"Crossref","is-referenced-by-count":102,"title":["Ipilimumab-induced acute severe colitis treated by infliximab"],"prefix":"10.1097","volume":"23","author":[{"given":"Cecile","family":"Pag\u00e8s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Gornet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gentiane","family":"Monsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Allez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bertheau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Lebb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuelle","family":"Viguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R5-10-20210129","first-page":"947","article-title":"Long term outcome of patients with active Crohns disease exhibiting extensive and deep ulcerations at colonoscopy.","volume":"97","author":"Allez","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1007\/s10620-008-0641-z","article-title":"Cytotoxic T-lymphocyte-associated antigen 4 antibody-induced colitis and its management with infliximab.","volume":"54","author":"Johnston","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1245\/s10434-008-0104-y","article-title":"CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues.","volume":"15","author":"Phan","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/cbr.2008.0607","article-title":"Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis.","volume":"24","author":"Minor","year":"2009","journal-title":"Cancer Biother Radiopharm"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0b013e32835fb524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:24:20Z","timestamp":1621887860000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201306000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e32835fb524","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}